Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Atriva Therapeutics GmbH, corporate

Atriva Therapeutics GmbH,

08.01.2020 - 16:02:10

Atriva Therapeutics to take part in three major conferences in San Francisco, USA, in the upcoming week

and follow us on LinkedIn and Twitter.

Contact: Atriva Therapeutics GmbH Dr. Rainer Lichtenberger, CEO phone: +49 7071 859 7673 mobile: +49 173 743 1897lichtenberger@atriva-therapeutics.com Media and Investor Relations: MC Services AG Raimund Gabriel / Eva Bauer phone: +49 89 21022880atriva-therapeutics@mc-services.eu

08.01.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

949123  08.01.2020 

@ dgap.de